| Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 333.57 crore and a net profit of Rs 3.80 crore for the quarter ended Jun '15. | | For the quarter ended Jun 2014 the consolidated total income from operations was Rs 313.72 crore and net loss was Rs 4.79 crore. | | Shasun Pharma shares closed at 384.55 on July 30, 2015 (NSE) and has given 35.21% returns over the last 6 months and 142.47% over the last 12 months. |
|
| | Shasun Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Jun '15 | Mar '15 | | | Jun '14 | | Net Sales/Income from operations | 319.17 | 336.10 | | | 299.77 | | Other Operating Income | 14.40 | 21.85 | | | 13.95 | | Total Income From Operations | 333.57 | 357.95 | | | 313.72 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 172.07 | 181.12 | | | 150.69 | | Purchase of Traded Goods | 0.62 | 1.51 | | | 1.74 | | Increase/Decrease in Stocks | -0.94 | -3.21 | | | 16.77 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 56.78 | 59.72 | | | 56.29 | | Depreciation | 14.46 | 12.94 | | | 12.28 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 74.32 | 78.25 | | | 71.29 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 16.26 | 27.62 | | | 4.66 | | Other Income | 1.09 | 4.48 | | | 1.91 | | P/L Before Int., Excpt. Items & Tax | 17.35 | 32.10 | | | 6.57 | | Interest | 12.36 | 12.90 | | | 11.58 | | P/L Before Exceptional Items & Tax | 4.99 | 19.20 | | | -5.01 | | Exceptional Items | -- | 7.85 | | | -- | | P/L Before Tax | 4.99 | 27.05 | | | -5.01 | | Tax | 1.18 | 6.31 | | | -- | | P/L After Tax from Ordinary Activities | 3.81 | 20.74 | | | -5.01 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | 3.81 | 20.74 | | | -5.01 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -0.01 | 1.42 | | | 0.22 | | Net P/L After M.I & Associates | 3.80 | 22.16 | | | -4.79 | | Equity Share Capital | 13.45 | 12.03 | | | 12.03 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | 0.61 | 3.69 | | | -0.83 | | Diluted EPS | 0.60 | 3.58 | | | -0.83 | | EPS After Extra Ordinary | | | | | | | Basic EPS | 0.61 | 3.69 | | | -0.83 | | Diluted EPS | 0.60 | 3.58 | | | -0.83 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 4.35 | 3.64 | | | 3.65 | | Share Holding (%) | 64.68 | 60.51 | | | 60.77 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 0.44 | 0.31 | | | 0.57 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 18.41 | 13.13 | | | 24.24 | | - Per. of shares (as a % of the total Share Cap. of the company) | 6.50 | 5.19 | | | 9.51 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 1.94 | 2.06 | | | 1.79 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 81.59 | 86.87 | | | 75.76 | | - Per. of shares (as a % of the total Share Cap. of the company) | 28.82 | 34.30 | | | 29.72 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
